Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder

Go back to Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder
(NASDAQ: AXSM) Delayed: 208.77 +2.09 (1.01%)
Previous Close $206.68    52 Week High $15.74 
Open $205.00    52 Week Low $5.37 
Day High $210.86    P/E N/A 
Day Low $202.00    EPS $0.00 
Volume 62,582